NICXF
Price
$0.30
Change
+$0.05 (+20.00%)
Updated
Jul 17 closing price
Capitalization
30.88M
NTRB
Price
$6.53
Change
+$0.12 (+1.87%)
Updated
Aug 28 closing price
Capitalization
72.68M
33 days until earnings call
Interact to see
Advertisement

NICXF vs NTRB

Header iconNICXF vs NTRB Comparison
Open Charts NICXF vs NTRBBanner chart's image
Nicox S.A
Price$0.30
Change+$0.05 (+20.00%)
Volume$8K
Capitalization30.88M
Nutriband
Price$6.53
Change+$0.12 (+1.87%)
Volume$14.52K
Capitalization72.68M
NICXF vs NTRB Comparison Chart in %
Loading...
NICXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NICXF vs. NTRB commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NICXF is a Hold and NTRB is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (NICXF: $0.30 vs. NTRB: $6.53)
Brand notoriety: NICXF and NTRB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NICXF: 147% vs. NTRB: 10%
Market capitalization -- NICXF: $30.88M vs. NTRB: $72.68M
NICXF [@Biotechnology] is valued at $30.88M. NTRB’s [@Biotechnology] market capitalization is $72.68M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NICXF’s FA Score shows that 0 FA rating(s) are green whileNTRB’s FA Score has 0 green FA rating(s).

  • NICXF’s FA Score: 0 green, 5 red.
  • NTRB’s FA Score: 0 green, 5 red.
According to our system of comparison, both NICXF and NTRB are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NICXF’s TA Score shows that 1 TA indicator(s) are bullish while NTRB’s TA Score has 6 bullish TA indicator(s).

  • NICXF’s TA Score: 1 bullish, 1 bearish.
  • NTRB’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, NTRB is a better buy in the short-term than NICXF.

Price Growth

NICXF (@Biotechnology) experienced а 0.00% price change this week, while NTRB (@Biotechnology) price change was +3.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.11%. For the same industry, the average monthly price growth was +20.33%, and the average quarterly price growth was +29.99%.

Reported Earning Dates

NTRB is expected to report earnings on Oct 01, 2025.

Industries' Descriptions

@Biotechnology (+2.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTRB($72.7M) has a higher market cap than NICXF($30.9M). NTRB YTD gains are higher at: 38.641 vs. NICXF (25.000).
NICXFNTRBNICXF / NTRB
Capitalization30.9M72.7M43%
EBITDAN/A-9.68M-
Gain YTD25.00038.64165%
P/E RatioN/AN/A-
RevenueN/A2.4M-
Total CashN/A2.96M-
Total DebtN/A282K-
FUNDAMENTALS RATINGS
NICXF vs NTRB: Fundamental Ratings
NICXF
NTRB
OUTLOOK RATING
1..100
4192
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
69
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5563
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a21

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NTRB's Valuation (69) in the null industry is in the same range as NICXF (92). This means that NTRB’s stock grew similarly to NICXF’s over the last 12 months.

NTRB's Profit vs Risk Rating (100) in the null industry is in the same range as NICXF (100). This means that NTRB’s stock grew similarly to NICXF’s over the last 12 months.

NTRB's SMR Rating (100) in the null industry is in the same range as NICXF (100). This means that NTRB’s stock grew similarly to NICXF’s over the last 12 months.

NICXF's Price Growth Rating (55) in the null industry is in the same range as NTRB (63). This means that NICXF’s stock grew similarly to NTRB’s over the last 12 months.

NICXF's P/E Growth Rating (100) in the null industry is in the same range as NTRB (100). This means that NICXF’s stock grew similarly to NTRB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NICXFNTRB
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
N/A
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
76%
MACD
ODDS (%)
Bearish Trend 1 day ago
29%
Bullish Trend 1 day ago
69%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
12%
Bullish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
10%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
N/A
Bullish Trend 7 days ago
82%
Declines
ODDS (%)
N/A
Bearish Trend 15 days ago
88%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
82%
Aroon
ODDS (%)
Bullish Trend 1 day ago
38%
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
NICXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DRRSF0.11N/A
+2.57%
Arianne Phosphate Inc
SSILF0.12N/A
N/A
Sa Sa International Holdings Ltd.
DSHKO7.50N/A
N/A
Drive Shack Inc.
ONTTF2.57-0.12
-4.46%
Oxford Nanopore Technologies PLC
TIAIY5.39-0.39
-6.80%
Telecom Italia S.p.A.

NICXF and

Correlation & Price change

A.I.dvisor indicates that over the last year, NICXF has been loosely correlated with MDXXF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if NICXF jumps, then MDXXF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NICXF
1D Price
Change %
NICXF100%
N/A
MDXXF - NICXF
46%
Loosely correlated
-0.94%
CLVLF - NICXF
22%
Poorly correlated
N/A
LADX - NICXF
20%
Poorly correlated
-15.31%
NTRB - NICXF
19%
Poorly correlated
+1.87%
COEP - NICXF
2%
Poorly correlated
-4.95%
More

NTRB and

Correlation & Price change

A.I.dvisor tells us that NTRB and VRAX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NTRB and VRAX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTRB
1D Price
Change %
NTRB100%
+1.87%
VRAX - NTRB
31%
Poorly correlated
+3.38%
ABSI - NTRB
28%
Poorly correlated
-3.14%
SYRE - NTRB
27%
Poorly correlated
-2.45%
STOK - NTRB
27%
Poorly correlated
+2.44%
DNLI - NTRB
26%
Poorly correlated
+0.32%
More